Managing legal risk in AI-powered pharmacovigilance: a Q&A with Merck

Updated as of: 15 January 2026
As regulators worldwide scrutinise AI use in pharmacovigilance, in-house counsel must address thorny questions. Who bears responsibility when algorithms fail? How do you audit black-box systems? Merck's legal and PV teams explain their approach to managing these emerging risks